Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1971 1
1972 1
1973 2
1974 6
1975 2
1977 1
1978 2
1979 2
1980 1
1981 1
1982 8
1983 4
1984 3
1985 4
1986 3
1987 3
1988 4
1989 11
1990 2
1991 10
1992 3
1993 7
1994 8
1995 5
1996 6
1997 4
1998 8
1999 4
2000 9
2001 2
2002 4
2004 5
2005 2
2006 7
2007 2
2009 1
2010 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Results by year
Filters applied: . Clear all
Page 1
Role of chemokines in severe asthma.
Murray LA, Syed F, Li L, Griswold DE, Das AM. Murray LA, et al. Among authors: griswold de. Curr Drug Targets. 2006 May;7(5):579-88. doi: 10.2174/138945006776818674. Curr Drug Targets. 2006. PMID: 16719768 Review.
Re-classification of NSAIDs.
Griswold DE, Ruffolo RR, Poste G, Torphy TJ. Griswold DE, et al. Trends Pharmacol Sci. 1997 Sep;18(9):311-2. Trends Pharmacol Sci. 1997. PMID: 9345847 No abstract available.
Biopharmaceutical therapeutics for asthma remodeling.
Das AM, Griswold DE, Torphy TJ, Li L. Das AM, et al. Among authors: griswold de. Curr Pharm Des. 2006;12(25):3233-40. doi: 10.2174/138161206778194097. Curr Pharm Des. 2006. PMID: 17020531 Review.
Biologic actions and pharmacokinetic studies of auranofin.
Walz DT, DiMartino MJ, Griswold DE, Intoccia AP, Flanagan TL. Walz DT, et al. Among authors: griswold de. Am J Med. 1983 Dec 30;75(6A):90-108. doi: 10.1016/0002-9343(83)90481-3. Am J Med. 1983. PMID: 6318557 Review.
Monoclonal antibodies as a strategy for pulmonary diseases.
Torphy TJ, Li L, Griswold DE. Torphy TJ, et al. Among authors: griswold de. Curr Opin Pharmacol. 2001 Jun;1(3):265-71. doi: 10.1016/s1471-4892(01)00047-9. Curr Opin Pharmacol. 2001. PMID: 11712750 Review.
Coming of age: anti-cytokine therapies.
Song XY, Torphy TJ, Griswold DE, Shealy D. Song XY, et al. Among authors: griswold de. Mol Interv. 2002 Feb;2(1):36-46. doi: 10.1124/mi.2.1.36. Mol Interv. 2002. PMID: 14993360 Review.
Inhibition of p38 MAP kinase as a therapeutic strategy.
Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Lee JC, et al. Among authors: griswold de. Immunopharmacology. 2000 May;47(2-3):185-201. doi: 10.1016/s0162-3109(00)00206-x. Immunopharmacology. 2000. PMID: 10878289 Review.
151 results